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Herein, we report a case of paraneoplastic pemphigus with mild skin features of pemphigus foliaceus and lichenoid stomatitis
associated with B-cell lymphoma. A 49-year-old man presented with scattered blisters and erosions on the trunk along with
mucosal blisters and erosions. Skin biopsy showed subcorneal acantholytic bulla and oral mucosal biopsy demonstrated lichenoid
dermatitis. Direct immunoﬂuorescence showed cell surface deposits of IgG and C3. Indirect immunoﬂuorescence identiﬁed
circulating IgG autoantibodies to the cell surfaces of normal human skin and also on the transitional epithelium of rat bladder.
Enzyme-linked immunosorbent assay using recombinant baculoproteins showed positive antidesmoglein 1 autoantibodies (index
46)butnegativeantidesmoglein3autoantibodies(index8).Immunoblotanalysisusingnormalhumanepidermalextractdetected
BP230 and the 190kDa periplakin, while immunoprecipitation using radiolabeled cultured keratinocyte immunoprecipitated
BP230 and the 210kDa envoplakin. We consider that the skin lesion was produced by humoral immunity whereas the oral lesion
was produced by cellular immunity.
1.Introduction
Paraneoplastic pemphigus (PNP) was ﬁrst reported in 1990
by Anhalt et al. as an autoimmune blistering disorder
associated mostly with lymphoproliferative malignancies
with characteristic clinical presentation and immunological
ﬁndings [1, 2]. Recently PNP has been recognized as a
wide spectrum of clinical and histological diseases with
variable autoantibody proﬁle involving both humoral and
cellular autoimmunity response [1]. We report a case of
PNP with cutaneous features of pemphigus foliaceus (PF)
and lichenoid stomatitis and antibodies that were reactive
with rat bladder epithelium. Interestingly, enzyme-linked
immunosorbent assay (ELISA) detected only antidesmoglein
1 (Dsg1) antibodies but not anti-Dsg3 antibodies. The
results of immunoblotting and immunoprecipitation were
complex.
2.CaseReport
A 49-year-old man presented with a 4-month history of
oral lesion and a one-month history of skin lesions on the
trunk. He had been admitted to the Department of Internal
Medicine for evaluation of an abdominal mass with pain.
His past history was unremarkable. On examination, he
had blisters and erosions on the buccal mucosa, tongue
and lips (Figure 1). The oral lesions did not extend onto
the vermillion of the lips. He also had several scattered
crusted and erosive lesions with small ﬂaccid bullae on
the chest and back (Figure 2). No lichenoid lesions were
observed on skin. Biopsy of the ﬂaccid bulla on the chest
showed subcorneal bulla formation with mild acantholysis
(Figure 3). No interface dermatitis was seen histologically.
Histopathological ﬁndings of the oral mucosa revealed
severe lichenoid dermatitis with dyskeratotic cells (Figure 4).2 Dermatology Research and Practice
Figure 1: Blisters and erosions on the buccal mucosa, tongue, and
lips. Oral lesions did not extend onto the vermillion of the lips.
Figure 2: Scattered crusted and erosive lesions with ﬂaccid bullae
on the chest.
Direct immunoﬂuorescence of the perilesional skin showed
intercellular deposits of IgG throughout epidermis and
intercellular deposits of C3 in the lower layer of epidermis
(Figure 5). Direct immunoﬂuorescence of the oral mucosa
showed cell surface deposits of IgG and C3 in the lower layer
of epithelium with ovoid bodies of IgG and IgM (Figure 6).
Indirect immunoﬂuorescence (IIF) revealed anticell surface
antibodies at a titer of 1:160 with normal human skin. IIF
was also positive using monkey esophagus and rat bladder
epithelium as a substrate (Figure 7)[ 1]. Anti-Dsg1 antibody
index was 46 (positive) and anti-Dsg3 antibody index was
8 (negative) by ELISA using baculovirus protein. Anti-
BP230 antibodies and anti-BP180 antibodies were negative
by ELISA. By immunoblot analysis using normal human
epidermal extract [3], the patient’s serum reacted with
BP230 and the 190kDa periplakin, but not with the 210kDa
envoplakin (Figure 8). In contrast, by immunoprecipitation
using radiolabeled cultured keratinocytes [1], the serum of
this patient immunoprecipitated the 250kDa desmoplakin
I, BP230 and envoplakin, but not the 215kDa desmoplakin
II, periplakin and the 170kDa unknown PNP antigen
(Figure 9).
100 μm
Figure 3: Histological ﬁndings of the skin lesion. Subcorneal bulla
with mild acantholysis. No interface dermatitis was seen.
100 μm
Figure 4: Histological ﬁndings of the oral lesion. Severe lichenoid
dermatitis with dyskeratotic cells.
A biopsy from the abdominal mass revealed B-cell
lymphoma (follicular center cell lymphoma). No pulmonary
involvement was seen. We diagnosed the patient with PNP.
The patient was transferred to another hospital for the
treatment of lymphoma and the clinical course of his
eruption thereafter was not known.
3. Discussion
Herein, we present a case of PNP with the clinical and
histological features of PF and lichenoid stomatitis in the
oral mucosa associated with B-cell lymphoma. This case
has the following features: (1) severe mucocutaneous blisters
and erosions; (2) histopathological ﬁndings of epidermal
acantholysisintheskin,dyskeratosisandinterfacechangesin
oral mucosa; (3) keratinocyte cell surfacedeposits of IgG and
C3 by direct immunoﬂuorescence; (4) serum autoantibodies
that were reactive with normal human skin, monkey esoph-
agus, and rat bladder epithelium; (5) immunoblot demon-
stration of antibodies to BP230 and the 190kDa periplakin;
(6) immunoprecipitation demonstration of antibodies to
desmoplakin I, BP230 and envoplakin; (7) association ofDermatology Research and Practice 3
Table 1: PNP cases with anti-Dsg1 antibodies but not with anti-Dsg3 antibodies.
No References Age/Sex Skin lesion Oral lesion IP IB ELISA
1 Chorzelski
et al. [8]
80/F widespread erythema,
bullae, erosions
bullae and
erosions
250kD 230kD
Dsg1: 190.6 (+)
Dsg3: 4.1 (−)
230kD 210kD
210kD 190kD
190kD 160kD
2 Martel
et al. [11] 70/M generalized lichenoid,
exfoliative erythroderma erosions NM
250kD
NM 210kD
190kD
160kD
3
Lee
et al. [10] 69/M annular erythema, with
bulla on extremities erosions
210kD
NM NM 190kD
160kD
4 Fukumoto
et al. [9]
64/F erythrodermic lichenoid
dermatitis and bullae erosions NM 210kD Dsg1: 70
Dsg3: (−) 190kD
5 Present case 49/M scattered bullae and
erosions on trunk
bullae and
erosions
250kD
230kD
190kD
Dsg1: 46 (+)
Dsg3: 8 (−) 230kD
210kD
IP: immunoprecipitation, IB: immunoblotting, NM: not mentioned.
Figure 5: Direct immunoﬂuorescence of the perilesional skin.
Intercellular deposits of IgG throughout epidermis.
B-cell lymphoma. According to these ﬁndings, this case
fulﬁlled the criteria of PNP proposed by Anhalt et al. [1, 2],
Hashimoto et al. [3], Camisa and Helm [4], and Joly et al.
[5], although the reactivity with the 210kDa envoplakin was
negative in immunoblot analysis and the 190kDa periplakin
and the 170kDa unknown PNP antigen were negative by
immunoprecipitation.
Initially,theresultofIIFusingratbladderepitheliumwas
negative in our case. We tested the IIF again with a diﬀerent
rat bladder epithelium substrate and obtained positive data.
Delayed detection of autoantibodies has also been reported
in PNP cases [6]. Therefore, it is important to repeat IIF
severaltimesusingdiﬀerentratbladdersubstrateifoneresult
is negative in cases of suspected PNP.
Amagai et al. reported that all patients with PNP had
antibodies to Dsg3 and half of them had antibodies to Dsg1
Figure 6: Direct immunoﬂuorescence of the oral mucosa. Cell
surface deposits of IgG in the lower layer of epithelium with ovoid
bodies.
Figure 7: Indirect immunoﬂuorescence was positive using rat
bladder epithelium as a substrate.4 Dermatology Research and Practice
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Figure 8: Results of immunoblot analysis using epidermal extract.
Patient’s sera taken on 2 diﬀerent occasions (lanes 4 and 5,
the time interval was 26 days) recognized BP230 and 190kDa
periplakin,whichwerealsodetectedbycontrolbullouspemphigoid
and control PNP sera. No reaction with 210kDa envoplakin was
observed. Lane 1: pemphigus vulgaris control serum, Lane 2: PNP
control serum, and Lane 3: bullous pemphigoid control serum. The
serum dilution was 1:20.
[7]. They also reported that anti-Dsg3 antibodies could lead
to blister formation in neonatal mice and suggested that
anti-Dsg3 antibodies are pathogenic in PNP. By contrast,
anti-Dsg1 antibodies could not induce blister formation in
neonatal mice. In the present case, the patient’s sera reacted
only with Dsg1, but did not react with Dsg3 by ELISA.
PNP cases with only anti-Dsg1 antibodies are very rare.
There have been only 4 cases reported in the English litera-
ture [8–11]. These cases are summarized in Table 1.I n2o f4
reported cases, anti-Dsg1 antibodies were detected by ELISA
as well as by immunoblot analysis and/or immunoprecipi-
tation. In one case, it was detected only by immunoblotting
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Figure 9: Results of immunoprecipitation using radiolabeled
cultured keratinocytes. Control PNP serum (PNP) immunoprecip-
itated the 250kDa desmoplakin I, BP230, the 215kDa desmoplakin
II,the210kDa envoplakin, the190kDaperiplakin, and the170kDa
unknown PNP antigen (lane 3). The serum of this patient (Patient)
immunoprecipitated desmoplakin I, BP230 and envoplakin (lane
2). Normal control serum (Normal) showed no positive reaction
(lane 1).
and in another case only by immunoprecipitation. In 3 of 4
reported cases, the clinical features are erythrodermic, wide
spread eruption. In one case, the clinical features resembled
linear IgA bullous dermatosis. Histologically, acantholysis or
cleavage was found at the level of the suprabasal layer in 2
cases and at the level of the upper epidermis in 2 cases. In 3
of 4 cases, lichenoid dermatitis was seen in skin biopsy. All 4
of the cases had oral mucosal erosions despite the absence of
anti-Dsg3 antibodies. All the cases had antibodies against the
210kDa envoplakin and the 190kDa periplakin detected by
immunoprecipitation and/or immunoblot.
The pathophysiologic mechanisms of the oral lesion
in these PNP cases with only anti-Dsg1 antibodies are
unknown. Chorzelski et al. suggested that there may be
another unidentiﬁed cell surface antigen for PNP, which is
related to blister formation in the oral mucous membrane
[8]. Fukumoto et al. suggested that other pathological
mechanisms, such as interface vacuolar dermatitis, might
be involved in the oral mucous membrane lesions in PNP
[9]. Unfortunately, no mucosal biopsy was performed in
these cases. In our case, mucosal biopsy revealed lichenoidDermatology Research and Practice 5
dermatitis. Therefore, we consider that interface dermatitis
might contribute to the formation of mucosal lesions in PNP
patients with only anti-Dsg1 antibodies.
Our present case has several ﬁndings that are unique
compared with typical PNP cases. First, the skin lesion
was very mild with scattered blisters and erosions on the
trunk. This clinical feature is also diﬀerent from most PNP
cases with anti-Dsg1 antibodies that exhibit widespread skin
eruption. The low titer of autoantibodies and the absence
of pathological lichenoid dermatitis may be the reason why
the skin eruption was mild in this patient. Histologically,
subcorneal acantholytic bulla, typical of PF, was seen in the
skin lesion. Therefore, it is convincing to consider that anti-
Dsg1 antibodies in this patient are pathogenic and can cause
skin eruption. Second, our patient had severe stomatitis, but
the oral lesion did not extend to the vermillion border of
the lips. In general the characteristic mucosal ﬁnding for
PNP is severe stomatitis extended to the vermillion border.
The absence of anti-Dsg3 antibodies may contribute to the
relatively limited oral lesion. Chorzelski et al. also reported
a case of PNP with anti-Dsg1 antibodies and observed that
the oral mucous membrane involvement was not as severe
as in typical cases of PNP [8]. Lastly, no reaction with the
210kDa envoplakin was seen with immunoblot analysis. We
didnotknowthereasonwhythe210kDaenvoplakinwasnot
detected. It was able to be detected by immunoprecipitation
because immunoprecipitation is a more sensitive test for the
detection of antibodies to the plakin family [3].
Recently Cummins et al. reported 4 cases of PNP without
detectable autoantibodies [12]. They concluded that the
spectrum of PNP likely to included patients with disease
predominantly or exclusively mediated by cytotoxic T cells
rather than autoantibodies. Cellular immunity is now likely
to be more important in the mechanism of PNP than
considered previously.
We consider the pathophysiological mechanism of the
disease in this patient to be as follows. B-cell lymphoma may
dysregulate cellular immunity and cause the oral lichenoid
lesion, resulting in damage to basal layer epithelial cells and
exposure to self-antigens. Subsequently, autoantibodies to
Dsg1 are formed, which produce the PF lesion on the trunk.
Based on the clinical and histological ﬁndings, we consider
that the skin lesion was produced by humoral immunity,
whereas the oral lesion was produced by cellular immunity.
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